[1] Mazzei L., Musiani F., Ciurli S.,
The Structure-based Reaction Mechanism of Urease, A Nickel Dependent Enzyme: Tale of a Long Debate,
JBIC Journal of Biological Inorganic Chemistry,
25(6): 829-845 (2020).
[2] Zambelli B., Mazzei L., Ciurli S.,
Intrinsic Disorder in the Nickel-Dependent Urease Network,
Progress in Molecular Biology and Translational Science, 174: 307-330 (2020).
[3] Ren C., Wang H., Cheng Y., Ma X., Wang Y.,
Cyclodextrin Polymer-Confined Urease for the Fast and Efficient Removal of Urea,
New Journal of Chemistry,
46(40): 19112-19117 (2022)
[4] de Fátima Â., de Paula Pereira C., Olímpio C.R.S.D.G., de Freitas Oliveira B.G., Franco L.L., da Silva P.H.C.,
Schiff bases and their Metal Complexes as Urease Inhibitors–A Brief Review,
Journal of Advanced Research,
13: 113-126 (2018).
[5] Yun-Tong L., Jing-Wen D., Yao L., Yi-Tong G., Chao-Nan S., Fu-Yao L., Zhong-Lu Y.,
Syntheses, Crystal Structures and Urease Inhibition of Two Manganesen (III) Complexes with Bis-Schiff Bases,
Chinese Journal of Inorganic Chemistry,
34(6): 1192-1198 (2018).
[7] Matczuk D., Siczek A.,
Effectiveness of the use of Urease Inhibitors in Agriculture: A Review,
International Agrophysics,
35: 197-208 (2021).
[9] Cunha E.S., Chen X., Sanz-Gaitero M., Mills D.J., Luecke H.,
Cryo-EM Structure of Helicobacter Pylori Urease with an Inhibitor in the Active Site at 2.0 Å Resolution,
Nature communications,
12(1): 1-8 (2021).
[10] Choi H., Jeong S.H., Kim T.Y., Yi J., Hahn S.K.,
Bioinspired Urease-Powered Micromotor as an Active Oral Drug Delivery Carrier in Stomach,
Bioactive materials,
9: 54-62 (2022).
[12] Rego Y.F., Queiroz M.P., Brito T.O., Carvalho P.G., de Queiroz V.T., de Fátima Â., Macedo J.F.,
A Review on the Development of Urease Inhibitors as Antimicrobial Agents Against Pathogenic Bacteria,
Journal of advanced research,
13: 69-100 (2018).
[13] Hameed A., Al-Rashida M., Uroos M., Qazi S.U., Naz S., Ishtiaq M., Khan K.M.,
A Patent Update on Therapeutic Applications of Urease Inhibitors,
Expert opinion on therapeutic patents,
29(3): 181-189 (2019).
[15] Yanai H., Iizasa H., Chihara D., Murakami T., Nishikawa J., Yoshiyama H.,
Epstein-Barr Virus Detection using Gastric Biopsy Specimens after Rapid Urease Test for Helicobacter Pylori,
Endoscopy International Open,
7(4): E431-E432 (2019).
[21] Faramarzi M., Pordel M., Morsali A.,
Synthesis, Antiviral, Antibacterial, and Cytotoxicity Assessment of some 3H-Benzo [a] Imidazo [4, 5-j] Acridines and 3H-Benzo [a] Pyrazolo [3, 4-j] Acridines,
Russian Journal of Organic Chemistry,
56(8): 1438-1445 (2020).
[22] Perrone R., Butovskaya E., Daelemans D., Palu G., Pannecouque C., Richter S.N.,
Anti-HIV-1 Activity of the G-Quadruplex Ligand BRACO-19, Journal of Antimicrobial Chemotherapy,
69(12): 3248-3258 (2014).
[23] Isaac I.O., Al-Rashida M., Rahman S.U., Alharthy R.D., Asari A., Hameed A., Iqbal J.,
Acridine-based (thio) Semicarbazones and Hydrazones: Synthesis, in Vitro Urease Inhibition, Molecular Docking and in-Silico ADME Evaluation,
Bioorganic chemistry,
82: 6-16 (2019).
[25] Hou Y., Shang C., Wang H., Yun J.,
Isatin–Azole Hybrids and their Anticancer Activities,
Archiv der Pharmazie,
353(1): 1900272 (2020).
[26] Rani D., Garg V., Dutt R.,
Anticancer Potential of Azole Containing Marine Natural Products: Current and Future Perspectives,
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents),
21(15): 1957-1976 (2021).
[27] Devasia J., Nizam A., Vasantha V.L.,
Azole-based Antibacterial Agents: A Review on Multistep Synthesis Strategies and Biology,
Polycyclic Aromatic Compounds,
42(8): 5474-5495 (2022).
[28] Das R., Asthana G.S., Suri K.A., Mehta D., Asthana A.,
Recent Developments in Azole Compounds as Antitubercular Agent,
Mini-Reviews in Organic Chemistry,
16(3): 290-306 (2019).
[29] de Castro Spadari C., Barreto T.L., de Queiroz V.T., de Paiva W.F., Fernandes S.A., de Fátima Â., Ishida K.,
Ketoconazole/Calix [n] Arenes-based Compounds Improve the Antifungal Activity Against Azole-Resistant Candida Isolates,
Journal of Medical Mycology,
32(2): 101254 (2022).
[31] Chaudhry F., Naureen S., Aslam M., Al‐Rashida M., Rahman J., Huma R., Ain Khan M.,
Identification of Imidazolylpyrazole Ligands as Potent Urease Inhibitors: Synthesis, Antiurease Activity and In Silico Docking Studies,
ChemistrySelect,
5(38): 11817-11821 (2020).
[32] Zaib S., Younas M.T., Zaraei S.O., Khan I., Anbar H.S., El-Gamal M.I.,
Discovery of Urease Inhibitory Effect of Sulfamate Derivatives: Biological and Computational Studies,
Bioorganic Chemistry,
119: 105545 (2022).
[33] Rafiq M., Saleem M., Jabeen F., Hanif M., Seo S.Y., Kang S.K., Lee K.H.,
Facile Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Substituted Azole Derivatives,
Journal of Molecular Structure,
1138: 177-191 (2017).
[34] Bektaş H., Ceylan Ş., Demirbaş N., Alpay-Karaoğlu Ş., Sökmen B.B.,
Antimicrobial and Antiurease Activities of Newly Synthesized Morpholine Derivatives Containing an Azole Nucleus,
Medicinal Chemistry Research,
22(8): 3629-3639 (2013).
[35] Abdulwahab H.G., Harras M.F., El Menofy N.G., Hegab A.M., Essa B.M., Selim A.A., El-Zahabi H.S.,
Novel Thiobarbiturates as Potent Urease Inhibitors with Potential Antibacterial Activity: Design, Synthesis, Radiolabeling and Biodistribution Study,
Bioorganic Medicinal Chemistry,
28(23): 115759 (2020).
[36] Islam M., Khan A., Shehzad M.T., Hameed A., Ahmed N., Halim S.A., Al-Harrasi A.,
Synthesis and Characterization of New Thiosemicarbazones, as Potent Urease Inhibitors: In Vitro and in Silico Studies,
Bioorganic chemistry,
87: 155-162 (2019).
[37] Song W.Q., Liu M.L., Li S.Y., Xiao Z.P.,
Recent Efforts in the Discovery of Urease Inhibitor Identifications,
Current Topics in Medicinal Chemistry,
22(2): 95-107 (2022).
[40] Takhti S., Pordel M., Davoodnia A., Bozorgmehr M.R.,
Imidazo [4′, 5′: 3, 4] Benzo [1, 2-e][1, 4] Diazepins as New Heterocyclic Systems: Synthesis, Characterization and Their in Vitro Interactions with Benzodiazepine Receptors,
Polycyclic Aromatic Compounds, 1-7 (2022).
[41] Anbarani H.M., Pordel M., Bozorgmehr M.R.,
Interaction of Imidazo [4, 5-a] Acridines with Acetylcholinesterase,
Pharmaceutical Chemistry Journal, 1-7 (2022).
[42] Ramezani S., Pordel M., Davoodnia A.,
Synthesis, Spectral, DFT Calculations and Antibacterial Studies of Fe (III) Complexes of New Fluorescent Schiff bases Derived from Imidazo [4', 5': 3, 4] Benzo [1, 2‐c] Isoxazole,
Applied Organometallic Chemistry,
32(3): e4178 (2018).
[43] Faramarzi M., Pordel M., Morsali A.,
Synthesis, Antiviral, Antibacterial, and Cytotoxicity Assessment of Some 3H-Benzo [a] imidazo [4, 5-j] acridines and 3H-Benzo [a] pyrazolo [3, 4-j] acridines,
Russian Journal of Organic Chemistry,
56(8): 1438-1445 (2020).
[44] Karimi N., Pordel M., Davoodnia A., Sadeghian H., Mousavian M.,
Synthesis, Characterization and Biological Evaluations of New Imidazo [4, 5-a] Acridines as Potential Antibacterial Agents,
Pharmaceutical Chemistry Journal,
53(1): 52-56 (2019).
[45] Adhikari A., Bhakta S., Ghosh T.,
Microwave-Assisted Synthesis of Bioactive Heterocycles: an Overview,
Tetrahedron, 133085 (2022).
[46] Pordel M.,
Synthesis of New Fluorescent Compounds from Benzimidazole,
Journal of Chemical Research,
36(10): 595-597 (2012).
[50] Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E.,
The Protein Data Bank,
Nucleic acids research,
28(1): 235-42 (2000).
[51] Zoete V., Cuendet M.A., Grosdidier A., Michielin O.,
SwissParam:
a Fast Force Field Generation Tool for Small Organic Molecules,
Journal of computational chemistry,
32: 2359-2368 (2011)
[52] Luenberger D.G., Ye Y., “Linear and Nonlinear Programming”, Vol. 2, Springer, (1984).
[53] Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G
., A Smooth Particle Mesh Ewald Method,
The Journal Of Chemical Physics,
103: 8577-8593 (1995).